在患有血液性恶性瘤的患者中对病的审查
Max Sheng1, Brandon Ritchie1, Sohrab Afshari Mirak1
1Department of Radiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106.
Radiology. Imaging cancer
|October 17, 2025
概括
侵入性菌病是一种致命的真菌感染在患有血液恶性瘤的患者,经常影响多个器官. 早期识别和多式联络成像对于改善这一高危人群的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 放射学 放射学是一门学科.
背景情况:
- 血液性恶性瘤显著增加了侵入性真菌病 (IFD) 的风险.
- 侵入性菌症是一种特别致命的IFD,在免疫功能低下的患者中死亡率高.
- 在患有血液性恶性瘤的患者中,IFD对发病率和死亡率做出了重大贡献.
研究的目的:
- 审查在患有血液性恶性瘤的患者中侵袭性fusarosis的各种临床和成像表现.
- 提供疾病表现,器官参与和治疗方法的多式概述.
- 讨论当前的诊断挑战和早期识别和管理的未来战略.
主要方法:
- 对已发表的血液恶性瘤患者的侵入性菌病例的审查.
- 突出不同的临床表现和器官参与 (皮肤,骨,中枢神经系统,心血管).
- 讨论多式成像技术,包括CT,PET/CT,超声波和MR成像.
主要成果:
- 侵袭性菌症呈现为一种使人虚弱的多器官感染.
- 在某些器官系统中,侵入性菌病的病例死亡率可以达到100%.
- 多模式成像在识别疾病表现方面发挥着关键作用.
结论:
- 提高认识和教育对于改善侵袭性菌病的诊断和治疗至关重要.
- 早期识别和管理对于改善血液恶性瘤患者的治疗结果至关重要.
- 多模式成像方法对于全面评估侵袭性菌症至关重要.
相关概念视频
Fungal Phylum Microsporidia
417
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
417
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


